BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 18990428)

  • 1. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
    Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
    Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human UDP-glucuronyltransferases on the formation of the methylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-methoxymethamphetamine 4-O-glucuronides.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Drug Metab Dispos; 2009 Nov; 37(11):2212-20. PubMed ID: 19666989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms.
    Nakajima M; Tanaka E; Kobayashi T; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Jun; 30(6):636-42. PubMed ID: 12019188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes.
    Yamanaka H; Nakajima M; Katoh M; Yokoi T
    Drug Metab Dispos; 2007 Sep; 35(9):1642-8. PubMed ID: 17591679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
    Yu L; Lu S; Lin Y; Zeng S
    Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
    Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
    Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
    Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
    Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
    Wen Z; Martin DE; Bullock P; Lee KH; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
    Chen M; LeDuc B; Kerr S; Howe D; Williams DA
    Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
    Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
    Watanabe Y; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms.
    Al-Zoughool M; Talaska G
    J Appl Toxicol; 2006; 26(6):524-32. PubMed ID: 17080401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.